Volume 15, Issue 2
PxWire is AVAC’s quarterly update on biomedical HIV prevention. Each issue highlights key developments, challenges and opportunities, and features a centerspread infographic that provides a visual tool for framing these issues.
The field of HIV prevention is confronted with two opposing forces; many programs for delivering PrEP have been shuttered all over the world by the withdrawal of the US government from global health, at the same moment as the newest next-generation long-acting PrEP product – injectable lenacapavir (LEN) – is poised to enter the market and help the world achieve epidemic control. These forces are colliding in real time.
All that and more in latest issue of PxWire.
Previous issues are available in our resource library.